Armata Pharmaceuticals earnings were -$192.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ARMP earnings report on Jun 30, 2026 announced Q2 2026 earnings of $74.1M, down 164.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARMP reported annual earnings of -$173.8M, with 818.8% growth. The next ARMP earnings date is Nov 11, 2026.
Armata Pharmaceuticals Earnings Reports & History FAQ
What were Armata Pharmaceuticals's earnings last quarter?
On ARMP's earnings call on Aug 11, 2026, Armata Pharmaceuticals (NYSEMKT: ARMP) reported Q2 2026 earnings per share (EPS) of $2.02, up 548.89% year over year. Total ARMP earnings for the quarter were $74.14 million. In the same quarter last year, Armata Pharmaceuticals's earnings per share (EPS) was -$0.45.
The next ARMP earnings date is Nov 11, 2026. Add ARMP to your watchlist to be reminded of Armata Pharmaceuticals's next earnings date.
Is Armata Pharmaceuticals profitable or losing money?
As of the last Armata Pharmaceuticals earnings report, Armata Pharmaceuticals is currently losing money. Armata Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$192.18 million, a 647.57% increase year over year.
What was ARMP's earnings growth in the past year?
As of Armata Pharmaceuticals's earnings date in Aug 11, 2026, Armata Pharmaceuticals's earnings has grown year over year. ARMP earnings in the past year totalled -$192.18 million.
What are Armata Pharmaceuticals's earnings expectations?
The current EPS estimate for Armata Pharmaceuticals's earnings report in Nov 11, 2026 is -$0.57.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.